new_0222_0731|DNA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0731|DNA|1|Ginkgo Bioworks Holdings Inc Total Current Assets (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Cash and Short Term Investments (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Inventories (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net PP&E (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Goodwill and Intangibles (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Current Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Long Term Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Deposits (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Book Value (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Retained Earnings (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Treasury Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc EV to Revenues|Ginkgo Bioworks Holdings Inc EV to Earnings|Ginkgo Bioworks Holdings Inc EV to Free Cash Flow|Ginkgo Bioworks Holdings Inc EV to Assets (Quarterly)|Ginkgo Bioworks Holdings Inc PS Ratio|Ginkgo Bioworks Holdings Inc PE Ratio|Ginkgo Bioworks Holdings Inc Price to Book Value|Ginkgo Bioworks Holdings Inc PEG Ratio|Ginkgo Bioworks Holdings Inc Debt to Equity Ratio|Ginkgo Bioworks Holdings Inc Dividend Yield|Ginkgo Bioworks Holdings Inc Shareholder Yield (TTM)|Ginkgo Bioworks Holdings Inc Percent of Shares Outstanding Short|Ginkgo Bioworks Holdings Inc Total Receivables (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Payables (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Capital Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Return on Invested Capital|Ginkgo Bioworks Holdings Inc Quality Ratio Score|Ginkgo Bioworks Holdings Inc Momentum Score|Ginkgo Bioworks Holdings Inc Beta (1Y)|Ginkgo Bioworks Holdings Inc Sustainable Growth Rate (TTM)|Ginkgo Bioworks Holdings Inc Institutional Investor Ownership Percentage|Ginkgo Bioworks Holdings Inc Average Diluted Shares Outstanding (Quarterly)|Ginkgo Bioworks Holdings Inc Total Employees (Annual)|Ginkgo Bioworks Holdings Inc EPS Diluted (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc SG&A Expense (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Shares Outstanding|Ginkgo Bioworks Holdings Inc Repurchase of Capital Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Ordinary Shares Number (Quarterly)|Ginkgo Bioworks Holdings Inc Payout Ratio|Ginkgo Bioworks Holdings Inc Quick Ratio (Quarterly)|Ginkgo Bioworks Holdings Inc Normalized Diluted EPS (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Stock Buybacks (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Effective Tax Rate (TTM)|Ginkgo Bioworks Holdings Inc Return on Equity|Ginkgo Bioworks Holdings Inc Net Income (TTM) (USD)|Ginkgo Bioworks Holdings Inc Revenue (TTM) (USD)|Ginkgo Bioworks Holdings Inc Dividend Per Share (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Revenue (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Gross Profit (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Pre-Tax Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net Interest Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Price (USD)|Ginkgo Bioworks Holdings Inc Total Return Price (USD)|Ginkgo Bioworks Holdings Inc Enterprise Value (USD)|Ginkgo Bioworks Holdings Inc 30-Day Average Daily Volume|Ginkgo Bioworks Holdings Inc 1 Year Price Returns (Daily)|Ginkgo Bioworks Holdings Inc Short Interest|Ginkgo Bioworks Holdings Inc PE Ratio (Forward)|Ginkgo Bioworks Holdings Inc PE Ratio (Forward 1y)|Ginkgo Bioworks Holdings Inc PS Ratio (Forward)|Ginkgo Bioworks Holdings Inc PS Ratio (Forward 1y)|Ginkgo Bioworks Holdings Inc Quarterly EPS Estimates (USD)|Ginkgo Bioworks Holdings Inc Quarterly Revenue Estimates (USD)|Ginkgo Bioworks Holdings Inc Quarterly EPS Surprise|Ginkgo Bioworks Holdings Inc Quarterly Revenue Surprise|Ginkgo Bioworks Holdings Inc Quarterly Actual EPS (USD)|Ginkgo Bioworks Holdings Inc Quarterly Actual Revenue (USD)|Ginkgo Bioworks Holdings Inc Revenue Estimates for Current Fiscal Year (USD)|Ginkgo Bioworks Holdings Inc Revenue Estimates for Next Fiscal Year (USD)|Ginkgo Bioworks Holdings Inc Price Target (USD)|Ginkgo Bioworks Holdings Inc Consensus Recommendation|Ginkgo Bioworks Holdings Inc Price Target Num Estimates|Ginkgo Bioworks Holdings Inc EPS Estimates for Current Fiscal Year (USD)|Ginkgo Bioworks Holdings Inc EPS Estimates for Next Fiscal Year (USD)|Ginkgo Bioworks Holdings Inc Research and Development Expense (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Reconciled Depreciation (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Non-Operating Interest Expense (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Land and Improvements (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Buildings and Improvements (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Other Properties (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0731|DNA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0731|DNA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|yearly|quarterly|yearly|yearly|monthly|yearly|quarterly|quarterly|quarterly|yearly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|yearly|yearly|yearly|yearly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|yearly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly||
new_0222_0731|DNA|5|||||||||||||||||||1.4387755102|||1.43192488263||15.375|||||||||30.75|365||365|365|26|365||||365|365||||||365|365|365|365|365|1.43192488263|1.43192488263|1.4387755102|1.44565217391||15.375|||1.44117647059|1.44117647059|91.4|91.4|||||8.93333333333|12|13.4|7.88235294118|13.4|10.3076923077|13.3333333333|365||365||||||
new_0222_0731|DNA|6|||||||||||||||||||98|||213||8|||||||||4|1||1|1|2|1||||1|1||||||1|1|1|1|1|213|213|98|184||8|||34|34|5|5|||||15|10|10|17|10|13|9|1||1||||||
new_0222_0731|DNA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0731|DNA|202009||||||||||||||||||||||||||||||||||1485.0612||-0.0175|9.876||||||-0.0175|||||||13.302|11.533|-26.12|-26.055|2.726||||||||||||||||||||||||36.07||0.592||||||
new_0222_0731|DNA|202103|||||||||||||||||||||||||||||||||||||||||||||||||||||||10.24|10.24||2921011.7333|||||||||||||||||||||||||||9.87|
new_0222_0731|DNA|202106|||||||||||||||||||||||||||||||||||||||||||||||||||||||9.96|9.96||2065526.5333|||||||||||||||||||||||||||9.87|9.97
new_0222_0731|DNA|202109|1810.569|1739.056|3.474|142.704|39.228|532.62|90.305|442.315||1551.551|-697.269|||||7.2345|||11.1057|||||0.6979|50.725|7.102|0.148||||||53.8017|1323.5741||-0.08|28.959|1486.7129|-24.998|1486.7129||19.8193|-0.0567|24.998||||||77.61|55.308|-102.612|-101.881|-0.528|11.59|11.59|15558.3665|6619342.7667||10376155|||||-0.035|46|-128.5714|68.7174|-0.08|77.61|175.221|179.221|14|1|1|-0.1105|-0.0989|53.021||0.649|||||13.82|11.87
new_0222_0731|DNA|202112|||||||||||||||||||7.9628|||||3.3043|||||||||51.9633||||||||||||||||||||||8.31|8.31|10682.126|9717813.2667||55269643|||49.5717|32.9741|-0.048|83.7953|||||239.7379|382.2666|14.1667|1.25|3|-0.2035|-0.1147||||||||5.98|4.65
new_0222_0731|DNA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.0425|76.079||||||||||||||||||||
new_0222_0731|DNA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.0475|71.4681||||||||||||||||||||
new_0222_0731|DNA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.05|70.7639||||||||||||||||||||
new_0222_0731|DNA|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.04|76.5667||||||||||||||||||||